Spontaneous canine gliomas: overexpression of EGFR, PDGFRalpha and IGFBP2 demonstrated by tissue microarray immunophenotyping. Read more about Spontaneous canine gliomas: overexpression of EGFR, PDGFRalpha and IGFBP2 demonstrated by tissue microarray immunophenotyping.
Adjuvant radiation therapy and chondroid chordoma subtype are associated with a lower tumor recurrence rate of cranial chordoma. Read more about Adjuvant radiation therapy and chondroid chordoma subtype are associated with a lower tumor recurrence rate of cranial chordoma.
High-dose chemotherapy and autologous stem cell rescue for atypical teratoid/rhabdoid tumor of the central nervous system. Read more about High-dose chemotherapy and autologous stem cell rescue for atypical teratoid/rhabdoid tumor of the central nervous system.
Large falcine meningioma fed by callosomarginal branch successfully removed following contralateral interhemispheric approach. Read more about Large falcine meningioma fed by callosomarginal branch successfully removed following contralateral interhemispheric approach.
Activation of PI3K/mTOR pathway occurs in most adult low-grade gliomas and predicts patient survival. Read more about Activation of PI3K/mTOR pathway occurs in most adult low-grade gliomas and predicts patient survival.
Primary gliosarcoma: key clinical and pathologic distinctions from glioblastoma with implications as a unique oncologic entity. Read more about Primary gliosarcoma: key clinical and pathologic distinctions from glioblastoma with implications as a unique oncologic entity.
A human brainstem glioma xenograft model enabled for bioluminescence imaging. Read more about A human brainstem glioma xenograft model enabled for bioluminescence imaging.
Phase II trials of erlotinib or gefitinib in patients with recurrent meningioma. Read more about Phase II trials of erlotinib or gefitinib in patients with recurrent meningioma.
Response of an adult patient with pineoblastoma to vorinostat and retinoic acid. Read more about Response of an adult patient with pineoblastoma to vorinostat and retinoic acid.
Suggested response criteria for phase II antitumor drug studies for neurofibromatosis type 2 related vestibular schwannoma. Read more about Suggested response criteria for phase II antitumor drug studies for neurofibromatosis type 2 related vestibular schwannoma.
